Influenza vaccines are recommended annually, but there’s now an increasing number of different vaccine types. Here’s what to know about this year’s shots.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
At this stage it’s hard to know for sure why Melbourne’s COVID numbers are higher, but it’s likely that climate plays a role.
We can do more in pursuing a zero-waste strategy in relation to sought-after COVID-19 vaccines.
There are three measures for assessing whether public policy is successful, and the Coalition has been found wanting on all three. But there’s one policy area that’s an even bigger disaster.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
Inconsistency, uncertainty and confusion are leading to vaccination delays.
The rare blood-clotting issues associated with the Astra-Zeneca vaccine have recently made headlines, but it's too early to say whether it will increase overall vaccine hesitancy.
Pharmacy students are underlining their value by taking their skills from the classroom to the COVID-19 frontline.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
With the COVID-19 pandemic still causing volatility, and the vaccine rollout just beginning, the next few months may prove to be the most difficult yet for the Morrison government.
The successful uptake of Australia’s COVID program hinges on tailored communication campaigns that appeal to all sectors of the community.
Unprecedented efforts are driving the global push for a safe and effective COVID-19 vaccine. Here's how it's likely to be rolled out in Australia.
Two Monash students – and also firm friends – are on a mission to boost the uptake of the influenza vaccine.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
Dr Harry Al-Wassiti is now part of a Monash research team striving to find a COVID-19 vaccine, but his path has been far from easy.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
Forget the finger-pointing – public communications that promote collective action will make our pandemic-clouded lives a little easier.
The adjuvanted flu vaccine is free for over-65s and offers better protection than the standard vaccine. Here's what the research says.
Monash is playing a leading role in the push to meet the United Nations' Sustainable Development Goals.
Sometimes, improving public health can mean infringing on people’s rights and compromising their interests.
HIV is no longer a death sentence, but the epidemic that has claimed nearly 40 million lives and ruined countless others isn’t over yet.
Two free flu vaccines will improve protection for older people, but like those already available, they're not perfect.
After a horrific 2017 flu season, there's more interest than ever in developing a better, more universal vaccine. T-cells might hold the answer.
Dummy text